Literature DB >> 8421178

Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.

C Urban1, E Go, N Mariano, B J Berger, I Avraham, D Rubin, J J Rahal.   

Abstract

A recent outbreak of multiresistant strains of Acinetobacter calcoaceticus biotype anitratus was observed mostly, but not exclusively, in the surgical intensive care unit in our hospital. Disk diffusion and microdilution susceptibility studies demonstrated resistance to imipenem, all aminoglycosides, and all individual beta-lactam antibiotics. Only ampicillin plus sulbactam, cefoperazone plus sulbactam, and polymyxin produced zone sizes and MICs in the susceptible ranges. Determination of MICs and MBCs demonstrated that sulbactam was the antimicrobial agent responsible for the killing of these organisms. Nine of 10 patients who were infected with imipenem-resistant Acinetobacter strains and received ampicillin plus sulbactam for > 3 days improved clinically, and in many cases organisms were eradicated from the site of isolation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421178     DOI: 10.1093/infdis/167.2.448

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  A short synthetic peptide, based on LyeTx I from Lycosa erythrognatha venom, shows potential to treat pneumonia caused by carbapenem-resistant Acinetobacter baumannii without detectable resistance.

Authors:  William Gustavo Lima; Júlio César Moreira Brito; Maria Elena de Lima; Amanda Cristina Silva Tardelli Pizarro; Maria Auxiliadora Martins de Mello Vianna; Magna Cristina de Paiva; Débora Cristina Sampaio de Assis; Valbert Nascimento Cardoso; Simone Odília Antunes Fernandes
Journal:  J Antibiot (Tokyo)       Date:  2021-05-10       Impact factor: 2.649

Review 2.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Task force on management and prevention of Acinetobacter baumannii infections in the ICU.

Authors:  José Garnacho-Montero; George Dimopoulos; Garyphallia Poulakou; Murat Akova; José Miguel Cisneros; Jan De Waele; Nicola Petrosillo; Harald Seifert; Jean François Timsit; Jordi Vila; Jean-Ralph Zahar; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2015-10-05       Impact factor: 17.440

4.  Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy.

Authors:  Micheal Nottingham; Christopher R Bethel; Sundar Ram Reddy Pagadala; Emily Harry; Abishai Pinto; Zachary A Lemons; Sarah M Drawz; Focco van den Akker; Paul R Carey; Robert A Bonomo; John D Buynak
Journal:  Bioorg Med Chem Lett       Date:  2010-11-05       Impact factor: 2.823

5.  Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia.

Authors:  G Christopher Wood; Scott D Hanes; Bradley A Boucher; Martin A Croce; Timothy C Fabian
Journal:  Intensive Care Med       Date:  2003-10-11       Impact factor: 17.440

6.  Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain.

Authors:  S López-Hernández; T Alarcón; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

7.  Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3.

Authors:  Krisztina M Papp-Wallace; Baui Senkfor; Julian Gatta; Weirui Chai; Magdalena A Taracila; Veerabahu Shanmugasundaram; Seungil Han; Richard P Zaniewski; Brian M Lacey; Andrew P Tomaras; Marion J Skalweit; Michael E Harris; Louis B Rice; John D Buynak; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

8.  Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.

Authors:  Jun Yong Choi; Chang Oh Kim; Yoon Seon Park; Hee Jung Yoon; So Youn Shin; Young Keun Kim; Myung Soo Kim; Yeon-A Kim; Young Goo Song; Dongeun Yong; Kyungwon Lee; June Myung Kim
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

Review 9.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

10.  Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India.

Authors:  A Gaur; A Garg; P Prakash; S Anupurba; T M Mohapatra
Journal:  J Health Popul Nutr       Date:  2008-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.